The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma von Buhl, R, Hanf, G, Soler, M, Bensch, G, Wolfe, J, Everhard, F, Champain, K, Fox, H, Thirlwell, J

Volltext

Omalizumab provides long-term control in patients with moderate-to-severe allergic asthma von Buhl, R, Soler, M, Matz, J, Townley, R, O'Brien, J, Noga, O, Champain, K, Fox, H, Thirlwell, J, Della Cioppa, G

Volltext

Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen–induced seasonal allergic rhinitis von Ädelroth, Ellinor, Rak, Sabina, Haahtela, Tari, Aasand, Gunbjörn, Rosenhall, Leif, Zetterstrom, Olle, Byrne, Aidan, Champain, Kate, Thirlwell, Jackie, Cioppa, Giovanni Della, Sandström, Thomas

Volltext

Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro von Ganeshaguru, K, Wickremasinghe, RG, Jones, DT, Gordon, M, Hart, SM, Virchis, AE, Prentice, HG, Hoffbrand, AV, Man, A, Champain, K, Csermak, K, Mehta, AB

Volltext

Validation of new clinical quantitative analysis software applicable in spine orthopaedic studies von Champain, S, Benchikh, K, Nogier, A, Mazel, C, Guise, J De, Skalli, W

Volltext